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Abstract
The cognitive deficits of schizophrenia appear to be associated with altered cortical GABA neurotransmission in the subsets
of inhibitory neurons that express either parvalbumin (PV) or somatostatin (SST). Identification of molecular mechanisms
that operate selectively in these neurons is essential for developing targeted therapeutic strategies that do not influence
other cell types. Consequently, we sought to identify, in the human cortex, gene products that are expressed selectively by
PV and/or SST neurons, and that might contribute to their distinctive functional properties. Based on previously reported
expression patterns in the cortex of mice and humans, we selected four genes: KCNS3, LHX6, KCNAB1, and PPP1R2,
encoding K+ channel Kv9.3 modulatory a-subunit, LIM homeobox protein 6, K+ channel Kvb1 subunit, and protein
phosphatase 1 regulatory subunit 2, respectively, and examined their colocalization with PV or SST mRNAs in the human
prefrontal cortex using dual-label in situ hybridization with 35S- and digoxigenin-labeled antisense riboprobes. KCNS3 mRNA
was detected in almost all PV neurons, but not in SST neurons, and PV mRNA was detected in .90% of KCNS3 mRNA-
expressing neurons. LHX6 mRNA was detected in almost all PV and .90% of SST neurons, while among all LHX6 mRNA-
expressing neurons 50% expressed PV mRNA and .44% expressed SST mRNA. KCNAB1 and PPP1R2 mRNAs were detected
in much larger populations of cortical neurons than PV or SST neurons. These findings indicate that KCNS3 is a selective
marker of PV neurons, whereas LHX6 is expressed by both PV and SST neurons. KCNS3 and LHX6 might be useful for
characterizing cell-type specific molecular alterations of cortical GABA neurotransmission and for the development of novel
treatments targeting PV and/or SST neurons in schizophrenia.
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Introduction
The core features of schizophrenia include disturbances in
diverse cognitive functions that depend on the neural circuitry of
the cerebral cortex [1]. In the cortex of subjects with schizophre-
nia, inhibitory neurotransmission mediated by c-aminobutyric
acid (GABA) appears to be altered [2], as indicated by lower levels
of the mRNAs encoding the 67 kilodalton isoform of glutamic acid
decarboxylase (GAD67) [3], the enzyme principally responsible for
GABA synthesis, and the GABA membrane transporter 1 (GAT1)
[4,5,6,7,8], which mediates the reuptake of synaptically released
GABA. These alterations appear to involve specific subsets of
GABA neurons. For example, the mRNAs encoding parvalbumin
(PV) and somatostatin (SST), each of which is expressed in a
separate subset of cortical GABA neurons, are decreased in
schizophrenia [7,9,10,11]. Moreover, the reductions in GAD67
and GAT1 appear to be prominent in PV- as well as SST-
expressing GABA neuron subsets [6,9,10]. On the other hand,
measures of the mRNA and protein for calretinin (CR), which is
expressed by a third subset of GABA neurons, were unaltered in
the cortex of subjects with schizophrenia [7,9,11,12,13,14].
Together, these findings indicate that cortical dysfunction in
schizophrenia selectively involves two separate subsets of GABA
neurons: PV and SST neurons.
Understanding the molecular processes underlying the alter-
ations in PV and SST neurons would be informed by identifying
molecules that are selectively expressed in these neurons and that
contribute to their distinctive functions. The evaluation of such
molecules in schizophrenia might also reveal affected molecular
pathways in PV and/or SST neurons, which could be used for
developing therapeutic strategies targeting selectively these neu-
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rons. In order to identify such molecules, we first used published
gene expression data for mouse cortical neuron subsets and
selected 70 genes found to be either developmentally upregulated
or preferentially enriched in PV and/or SST neurons [15,16,17].
We then evaluated the expression patterns of these 70 genes in the
online atlases of gene expression in the mouse or human cortex
[18] and excluded genes that were detected in pyramidal-like
neurons with an apical dendrite, or that exhibited an apparently
different laminar expression pattern from those of PV and/or SST
mRNAs. We found that KCNS3, LHX6, KCNAB1 and PPP1R2
had cortical mRNA expression patterns similar to those of PV
and/or SST mRNAs. KCNS3 encodes voltage-gated K+ channel
Kv9.3 modulatory a-subunit that coassembles with Kv2.1
a-subunits and leads to an enhanced conductance and modified
gating properties of the heteromeric channels [19,20,21]. LHX6
encodes LIM homeobox protein 6, a transcription factor suggested
to be involved in the development of PV and SST neurons in the
mouse cortex [22,23]. KCNAB1 encodes K+ channel Kvb1
accessory subunit that confers fast N-type inactivation to Kv1.1
channels [24]. PPP1R2 gene encodes protein phosphatase 1 (PP1)
regulatory subunit 2, which inhibits PP1 and controls signal
transduction and synaptic plasticity [25]. In this study, we
determined whether KCNS3, LHX6, KCNAB1 and PPP1R2
mRNAs are selectively expressed in PV and/or SST neurons in
the human prefrontal cortex (PFC).
Materials and Methods
Ethics Statement
All procedures were approved by the University of Pittsburgh
Committee for Oversight of Research and Clinical Training
Involving Decedents and Institutional Review Board for Biomed-
ical Research as well as by the Ethics Committee of Kanazawa
University Graduate School of Medical Science. All brain
specimens were obtained during autopsy at the Allegheny County
Medical Examiner’s Office (Pittsburgh, PA) after obtaining a
witnessed verbal consent from the next of kin, using a procedure
reviewed and approved by the University of Pittsburgh Committee
for Oversight of Research and Clinical Training Involving
Decedents. Verbal consent was audiotaped and a written
document summarizing the consent process was generated and
signed by the individual obtaining consent and an independent
witness.
Subjects
In this study we used post-mortem brain samples from four
control subjects (two males and two females; 41 to 62 years of age)
without a history of neurological or psychiatric diseases as
determined by clinical records, interviews with relatives, toxicology
results and neuropathological exams. Postmortem intervals and
brain pH were within the ranges of 9.2–11.6 hours and 6.2–6.6,
respectively, and RNA integrity numbers, which indicate the
integrity of RNA in the tissue, were between 7.8 and 9.0, assuring
their high quality for mRNA expression analyses [26].
Tissue Preparation and Single-label in Situ Hybridization
(ISH) with 35S-labeled Riboprobes
For each subject, the right PFC was blocked coronally,
immediately frozen, and stored at –80uC. Serial sections (20 mm)
containing the superior frontal gyrus were cut, thaw mounted onto
glass slides, and stored at –80uC until processed. The location of
PFC area 9 was identified by cytoarchitectonic criteria in Nissl-
stained sections as described previously [27]. Templates for the
synthesis of riboprobes were obtained by PCR using specific
primer sets for the studied genes (Table S1). For LHX6 and
KCNAB1, which have several splice isoforms, amplified fragments
were located in the common region among all isoforms.
Nucleotide sequencing revealed 100% homologies for all amplified
fragments to the reported sequences in Genbank. These fragments
were subcloned into the plasmid pSTBlue-1 (Novagen, Madison,
WI). Antisense and sense probes were transcribed in vitro in the
presence of 35S-CTP (PerkinElmer, Waltham, MA), using T7 or
SP6 RNA polymerase (Promega, Madison, WI). The templates
were then digested with RQ1 DNase (Promega), and riboprobes
were purified by centrifugation through the RNeasy mini spin
columns (Qiagen, Hilden, Germany). Hybridization was per-
formed as described previously [8,9,10]. For each gene, we
processed at least 2 sections per subject. After fixation with 4%
paraformaldehyde in PBS, the sections were acetylated with
0.25% acetic anhydrate in 0.1 M triethanolamine/0.9% NaCl for
10 min, and dehydrated through a graded ethanol series. The
sections were then hybridized with 35S-labeled riboprobes
(26107 dpm/ml) in hybridization buffer containing 50% form-
amide, 0.75 M NaCl, 20 mM 1,4-piperazine diethane sulfonic
acid, pH 6.8, 10 mM EDTA, 10% dextran sulfate, 56Denhardt’s
solution (0.2 mg/ml Ficoll, 0.2 mg/ml polyvinylpyrrolidone,
0.2 mg/ml BSA), 50 mM dithiothreitol, 0.2% SDS, and
100 mg/ml yeast tRNA at 56uC for 16 hr. The sections were
washed in a solution containing 0.3 M NaCl, 20 mM Tris-HCl,
pH 8.0, 1 mM EDTA, pH 8.0, and 50% formamide at 63uC,
treated with 20 mg/ml RNase A (Sigma-Aldrich, St Louis, MO) at
37uC, and washed in 0.16SSC (150 mM NaCl, 15 mM sodium
citrate) at 66uC. Sections were then dehydrated through a graded
ethanol series, air dried, and exposed to BioMax MR film (Kodak,
Rochester, NY) for 5–10 days. After the exposure to film, sections
were coated with NTB emulsion (Kodak) diluted 1:1 with distilled
water. To ensure the consistency of emulsion thickness across
sections, slides were dipped by using a mechanical dipper (Aiden,
Kobe, Japan), at a constant withdrawal speed (5 mm/s for
KCNAB1, 10 mm/s for LHX6 and PPP1R2, 15 mm/s for
KCNS3) and temperature (43uC). Sections were exposed for
7 days at 4uC, developed with D-19 (Kodak), and counterstained
with 0.5% cresyl violet (Sigma-Aldrich).
Film Autoradiographic Detection of mRNA Expression
Trans-illuminated autoradiographic film images were captured
by a video camera, digitized, and analyzed using a Microcomputer
Imaging Device (MCID) system (InterFocus Imaging Ltd, Cam-
bridge, UK). Images of adjacent sections stained with cresyl violet
were also captured and superimposed onto the autoradiographic
images to draw contours of pia mater and gray matter/white
matter border, and to denote the cortical layers. Optical density
was expressed as microcuries per gram of tissue (mCi/g) by
reference to Carbon-14 radioactive standards (ARC Inc., St.
Louis, MO) exposed on the same film.
Identification of Specifically Labeled Neurons by 35S-
labeled Riboprobes for KCNS3, LHX6, KCNAB1 and
PPP1R2 mRNAs
For the identification of specifically labeled neurons in the
following dual-label ISH analysis, a preparatory grain analysis
was performed using the sections that were processed for single-
label ISH and counterstained with cresyl violet. For each
mRNA, two 0.4-mm-wide stripes spanning the whole thickness
of the gray matter were sampled in at least one section from
each subject. Because RNase A treatment of sections destroyed
Nissl-stainable substances within the cytoplasm and made it
KCNS3 Expression in Cortical Parvalbumin Neurons
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difficult to draw contours of neuronal soma, we counted grains
within circles with a fixed size of 22 mm diameter that covered
the largest cross-sectional area of GABA neurons (<400 mm2)
observed in previous studies [27]. Using the MCID system
equipped with a microscope, we captured bright- as well as
dark-field images of the same views covering the entire cortical
stripes at high magnification. In the bright-field images, the
circles were centered over every Nissl-stained neuronal nucleus
and over glial nuclei that were not immediately adjacent to an
accumulation of grains (grain cluster). Small glial nuclei, stained
darkly with cresyl violet, were easily discriminated from large
and faintly stained neuronal nuclei (Figure S1). In the
corresponding dark-field images, the numbers of grains were
counted within each circle. Total numbers (mean 6 SD across
four subjects) of counted neurons were 1958 (490660), 1675
(419638), 2524 (631673), and 2675 (669657) and of counted
glial cells were 1845 (461655), 1009 (252629), 1494 (374642),
and 1145 (286623) for KCNS3, LHX6, KCNAB1 and
PPP1R2 mRNAs, respectively. For each mRNA, a histogram
of grain number per neuron (log10 transformed) for all sampled
neurons revealed a distribution that appeared bimodal,
presumably representing the modes of unlabeled and specifically
labeled neuron populations [28] (Figure S1). Similar histograms
of grain number per glial cell showed unimodal distribution for
all mRNAs, representing the unlabeled cellular population with
background grain numbers (Figure S1). In our dual-label ISH
analysis without the counterstaining, glial nuclei cannot be
visualized for the determination of background grain densities.
Therefore, in each section, we determined the number of grains
in a total of .0.1 mm2 cortical regions that do not contain any
grain clusters and calculated the gray matter background grain
number per 22-mm-diameter circle. For all studied mRNAs, a
threshold of 56 background provided a cutoff that excluded
glial cells and permitted the identification of specifically-labeled
neurons (Figure S1). Furthermore, the 56 background thresh-
olds were close to the point of rarity in the observed bimodal
distributions that represented both labeled and non-labeled
neurons (Figure S1). In a number of previous ISH studies using
emulsion autoradiography, the criterion of $56 background
was successfully used to define specifically labeled cells
[9,27,29,30].
Dual-label ISH
To directly assess colocalization of each of KCNS3, LHX6,
KCNAB1 and PPP1R2 mRNAs with PV or SST mRNAs, we
performed dual-label ISH. Templates for the synthesis of PV and
SST riboprobes were obtained by PCR using specific primer sets
(Table S1). Antisense riboprobes transcribed from these fragments
were shown to detect the specific signals of PV and SST mRNAs
[8,9,10]. In addition to the 35S-labeled riboprobes for KCNS3,
LHX6, KCNAB1 and PPP1R2 mRNAs, digoxigenin (DIG)-
labeled riboprobes for PV and SST mRNAs were transcribed
in vitro in the presence of DIG-11-UTP (Roche, Mannheim,
Germany). Sections were treated as described above except for the
combination of one of the four 35S-labeled probes and one of the
two DIG-labeled probes at concentrations of 26107 dpm/ml and
100 ng/ml, respectively, in hybridization buffer. After the
posthybridization washing, sections were preincubated with 3%
BSA in 100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Triton
X-100 for 30 min, incubated with anti-DIG antibody conjugated
with alkaline phosphatase (Roche) diluted 1:2000 in 1% BSA,
100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Triton X-100
for 12 hr at 4uC, washed in 100 mM Tris-HCl, pH 7.5, 150 mM
NaCl and air dried. To detect KCNS3, LHX6, KCNAB1 or
PPP1R2 mRNAs, sections were coated with NTB emulsion and
developed as described above. For the detection of PV or SST
mRNAs, sections were incubated in 0.5 mg/ml nitroblue tetrazo-
lium and 0.19 mg/ml bromo-chloroindolylphosphate (Roche) in
Figure 1. PV, SST, KCNS3, LHX6, KCNAB1 and PPP1R2 mRNA expression in the human PFC. Each mRNA was detected with a specific 35S-
labeled antisense riboprobe. Signal intensity (mCi/g) for each mRNA in the film autoradiograms is represented in a pseudocolor manner according to
the corresponding color scales. Roman numerals indicate the cortical layers, continuous white line indicates pia mater and a dashed line indicates the
white matter/gray matter border.
doi:10.1371/journal.pone.0043904.g001
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100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2 for
24 hr. In dark-field images, circles of 22 mm diameter were
centered onto visually identified grain clusters and those which
contained grains $56 background (measured for each section in
the gray matter) were considered specifically labeled for KCNS3,
LHX6, KCNAB1 or PPP1R2 mRNAs. In bright-field images,
DIG-riboprobe positive cells were distinguished by the precipita-
tion of alkaline phosphatase-produced color product in the cell
body. We have analyzed one section per each of the four subjects
for each of the eight possible combinations of 35S-labeled and
DIG-labeled riboprobes. For each section, single- and double-
labeled cells were plotted by Neurolucida 9.0 (MBF Bioscience,
Williston, VT) and counted separately in three 1-mm-wide cortical
stripes. The percentages of dual-labeled cells within a given
neuron subset were reported as mean 6 SD across the four
subjects.
Results
Cortical Expression of KCNS3, LHX6, KCNAB1 and PPP1R2
mRNAs
Single-label ISH with 35S-labeled antisense riboprobes revealed
specific laminar patterns of PV, SST, KCNS3, LHX6, KCNAB1
and PPP1R2 mRNA expression in the human PFC (Figure 1). In
emulsion-coated slides observed at high magnifications, grain
clusters for all mRNAs were observed over neuronal nuclei, but
not glial nuclei, indicating that the majority of positive cells are
neurons (Figure S1). Several additional lines of evidence confirmed
the specificity of the riboprobes for KCNS3, LHX6, KCNAB1 or
PPP1R2 mRNAs. First, the laminar distributions of KCNS3,
LHX6 and KCNAB1 mRNAs were consistent with previously
reported distributions in the rodent and human cortex
[18,22,31,32]. Second, for all four mRNAs, accumulations of
silver grains over neuronal and not glial nuclei were consistent
with their reported expression in cortical neurons [16,17]. Third,
sense riboprobes for KCNS3, LHX6, KCNAB1 or PPP1R2
mRNAs did not detect any signals above background (data not
shown). The specificities of the PV and SST riboprobes were
demonstrated in our previous studies [8,9,10].
Similar to the expression pattern of PV mRNA (Figure 1A),
KCNS3 mRNA signals were high in layers II to V, with the
highest signal density in layer IV (Figure 1C). The signals for
LHX6 mRNA were moderate in layers II-III and higher in layers
IV–VI, and some LHX6 mRNA signals were detected in the white
matter just below the gray matter (Figure 1D). This distribution
pattern appeared to correspond to the combined distribution of
PV and SST mRNAs (Figures 1A and B). KCNAB1 mRNA signal
densities were high throughout layers II-VI with a prominent
accumulation in layer IV and superficial layer V (Figure 1E).
PPP1R2 mRNA signals were detected almost evenly across layers
II–VI with some accumulation in layer IV (Figure 1F). No specific
hybridization signal was detected in layer I for any of the mRNAs
studied.
KCNS3, LHX6, KCNAB1 and PPP1R2 mRNA Expression in
PV and SST Neurons
In order to determine if KCNS3, LHX6, KCNAB1 and
PPP1R2 mRNAs were colocalized with PV or SST mRNAs, we
performed dual-label ISH with a 35S-labeled antisense riboprobe
for one of KCNS3, LHX6, KCNAB1 and PPP1R2 mRNAs and a
DIG-labeled antisense riboprobe for PV or SST mRNAs.
KCNS3, LHX6, KCNAB1 and PPP1R2 mRNAs were detected
by accumulations of silver grains generated in emulsion layer by
the corresponding 35S-labeled riboprobe. The neurons that
Figure 2. KCNS3, LHX6, KCNAB1 and PPP1R2 mRNAs detected simultaneously with PV or SST mRNAs. The signals for each of KCNS3,
LHX6, KCNAB1 and PPP1R2 mRNAs were detected by 35S-labeled antisense riboprobes as silver grain clusters (white arrows), while signals for PV or
SST mRNAs were detected by DIG-labeled antisense riboprobes as color reaction products (black arrows). Cells detected by both 35S- and DIG-labeled
antisense riboprobes are shown with half white half black arrows.
doi:10.1371/journal.pone.0043904.g002
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express each of these mRNAs were identified as grain clusters with
grain densities $56 background within 22 mm-diameter circles
centered on each cluster (see Materials and Methods), whereas the
neurons expressing either PV or SST mRNAs were visualized by
color reaction of alkaline phosphatase that was conjugated to anti-
DIG antibodies (Figure 2). Neurons detected with either a 35S-
labeled, a DIG-labeled, or both 35S-labeled and DIG-labeled
riboprobes were independently plotted and counted within three
1-mm-wide cortical stripes per subject, each traversing from the
pial surface through the entire thickness of cortex (Figure 3).
Quantitative data of the numbers of labeled neurons for each
combination of 35S- and DIG-labeled riboprobes are summarized
in Table 1.
Grain clusters representing KCNS3 mRNA-expressing neurons
were observed over 99.960.2% of PV neurons, and 91.061.3% of
the KCNS3 mRNA-positive grain clusters were labeled for PV
mRNA (Figures 2A and 3A, Table 1). In contrast, only 1.560.3%
of SST neurons contained grain clusters for KCNS3 mRNA, and
1.660.3% of such grain clusters were colocalized with SST
mRNA (Figures 2B and 3B, Table 1). These data indicate that
KCNS3 mRNA is specifically expressed by virtually all PV
neurons. In addition, the absence of KCNS3 mRNA in the
majority of SST neurons was consistent with the non-overlapping
expression of PV and SST in cortical GABA neurons [33,34].
Grain clusters representing LHX6 mRNA-expressing neurons
were observed over 99.960.2% of PV neurons. However,
50.061.5% of LHX6 mRNA-expressing neurons were labeled
for PV mRNA (Figures 2C and 3C, Table 1). Similarly, grain
clusters for LHX6 mRNA-expressing neurons were observed over
the majority (91.066.7%) of SST neurons, whereas 44.962.7% of
LHX6 mRNA expressing neurons were labeled for SST mRNA
(Figures 2D and 3D, Table 1). Given that PV and SST neurons
represent non-overlapping cortical GABA neuron subsets [33,34],
these data demonstrate that nearly all (.94%) of LHX6 mRNA-
expressing neurons are accounted for by the combination of PV
and SST neurons.
Grain clusters representing KCNAB1 mRNA-expressing neu-
rons were observed over all PV neurons and 23.564.3% of SST
neurons. However the majority (.68%) of grain clusters for
KCNAB1 mRNA-expressing neurons did not have signals for PV
or SST mRNAs (Figures 2E, F and 3E, F, Table 1). Grain clusters
representing PPP1R2 mRNA-expressing neurons were observed
over 98.960.7% PV neurons and 34.967.9% of SST neurons.
However, the majority (.72%) of grain clusters for PPP1R2
mRNA-expressing neurons did not have signals for PV or SST
mRNAs (Figures 2G, H and 3G, H, Table 1). These findings
indicate that KCNAB1 and PPP1R2 mRNAs were expressed by
much larger populations of cortical neurons than PV or SST
neurons.
Discussion
In dual-label ISH, KCNS3 mRNA was detected in almost all
PV neurons, but not in SST neurons, and PV mRNA was detected
in .90% of KCNS3 mRNA-expressing neurons. LHX6 mRNA
was detected in almost all PV and .90% of SST neurons, while
among all LHX6 mRNA-expressing neurons 50% expressed PV
mRNA and .44% expressed SST mRNA. KCNAB1 and
PPP1R2 mRNAs were detected in much larger populations of
cortical neurons than PV or SST neurons. Thus, KCNS3 mRNA
appears to be a selective marker of PV neurons, whereas LHX6
mRNA is expressed almost exclusively by both PV and SST
neurons. Only minor fractions of KCNS3 mRNA-expressing
neurons (,8%) and LHX6 mRNA-expressing neurons (,6%) do
not appear to express either PV or SST mRNAs (Table 1). These
neurons might overlap with other minor subsets of cortical
neurons [33].
For assessing coexpression of two molecules in single cells, ISH
detection of mRNAs has several advantages over the detection of
proteins by immunohistochemistry (IHC). First, because of
predominant somal expression of most mRNAs, ISH can
demonstrate directly overlapping signals for two mRNAs in the
soma. On the other hand, differences in subcellular distribution of
certain proteins and polypeptides among neuronal subtypes may
mask the detection of their expression by IHC in certain cell types.
For example, the majority of cholecystokinin (CCK) immunore-
active somata in the cortex were shown to be GABA neurons, but
not pyramidal neurons [35]. However, CCK mRNA could be
Figure 3. Cortical distributions of single- and dual-labeled cells. Neurolucida plots of single- and dual-labeled cells in representative cortical
stripes for each of the eight dual-label ISH experiments performed with the combination of one 35S-labeled antisense riboprobe for KCNS3, LHX6,
KCNAB1 or PPP1R2 mRNAs and one DIG-labeled antisense riboprobe for PV or SST mRNAs. 35S-riboprobe single-labeled cells are shown with white
circles, DIG-riboprobe single-labeled cells are shown with circled dots, and dual-labeled cells are shown with black circles.
doi:10.1371/journal.pone.0043904.g003
Table 1. Total numbers of counted single- and dual-labeled neurons and relative percentages{ of dual-labeled neurons.
Neurons detected
with 35S-labeled
riboprobe
Neurons detected
with DIG-labeled
riboprobe
Neurons detected with
both riboprobes
Percentage of dual-labeled neurons
among all neurons detected with 35S-
labeled riboprobe
Percentage of dual-labeled neurons
among all neurons detected with DIG-
labeled riboprobe
KCNS3 (1452) PV (1323) KCNS3&PV (1322) KCNS3&PV/KCNS3 (91.061.3%) KCNS3&PV/PV (99.960.2%)
KCNS3 (1187) SST (1239) KCNS3&SST (19) KCNS3&SST/KCNS3 (1.660.3%) KCNS3&SST/SST (1.560.3%)
LHX6 (2433) PV (1218) LHX6&PV (1217) LHX6&PV/LHX6 (50.061.5%) LHX6&PV/PV (99.960.2%)
LHX6 (2406) SST (1194) LHX6&SST (1080) LHX6&SST/LHX6 (44.962.7%) LHX6&SST/SST (91.066.7%)
KCNAB1 (4687) PV (1161) KCNAB1&PV (1161) KCNAB1&PV/KCNAB1 (25.363.3%) KCNAB1&PV/PV (100%)
KCNAB1 (4046) SST (1054) KCNAB1&SST (253) KCNAB1&SST/KCNAB1 (6.161.0%) KCNAB1&SST/SST (23.564.3%)
PPP1R2 (6393) PV (1304) PPP1R2&PV (1290) PPP1R2&PV/PPP1R2 (20.464.3%) PPP1R2&PV/PV (98.960.7%)
PPP1R2 (6110) SST (1210) PPP1R2&SST (426) PPP1R2&SST/PPP1R2 (6.961.0%) PPP1R2&SST/SST (34.967.9%)
{Percentages are given as mean 6 SD across the four control subjects.
doi:10.1371/journal.pone.0043904.t001
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easily detected in the pyramidal neuron somata with ISH [36].
This discrepancy was explained by the predominant accumulation
of CCK protein in the axon terminals, but not in the somata, of
pyramidal neurons [37]. Second, ISH with 35S-labeled riboprobes
has a high sensitivity that enables the detection of as few as
10 mRNA copies per cell [38], whereas the sensitivity of IHC,
which depends on the specificity of antibodies, might not be high
enough to identify cells containing low levels of target proteins.
Third, in ISH with emulsion autoradiography, specifically labeled
cells are identified using quantitatively determined cut-offs based
on the distribution of grain numbers per cell, whereas in IHC,
identification of positive cells tends to depend on visual impression
which is less reliable for cells with weak immunopositive signals.
These methodological factors might explain why PPP1R2 was
demonstrated to be selective to PV neurons by IHC in the mouse
cortex [17], but in our ISH study, PPP1R2 mRNA was detected in
a larger neuronal population than PV neurons. Although the types
of cortical neurons that express PPP1R2 might differ between
mouse and human, the absence of protein signals and the presence
of mRNA for PPP1R2 in many non-PV neurons might reflect a
subcellular localization or the low expression levels of PPP1R2
protein in non-PV neurons.
LHX6, which encodes a LIM homeobox transcription factor,
regulates the development of PV and SST neurons, both of which
originate from the medial ganglionic eminence (MGE)
[22,23,31,39,40]. In LHX6 knockout mice, the tangential
migration of GABA neuron progenitors from the MGE to the
cortex was delayed and the subsequent radial migration of these
progenitors within the cortical plate appeared to be disturbed,
resulting in an abnormal cortical distribution of GABA neurons
[22,23]. The knockout mice also exhibited severely reduced
numbers of PV and SST neurons, indicating that LHX6 is
important for the phenotypic differentiation of these neurons
[22,23]. Furthermore, the persistent expression of LHX6 after
development suggests its role in the maintenance of physiological
and morphological properties of mature PV and SST neurons
[16,31]. We recently reported decreased LHX6 mRNA levels in
the PFC of subjects with schizophrenia [14]. Interestingly, a subset
of schizophrenia subjects was identified by the presence of
consistent deficits in LHX6, GAD67, PV and SST mRNAs,
suggesting that LHX6 deficits may affect development and/or
maintenance of GABAergic phenotype in PV and SST neurons in
these subjects. Identifying genes that are regulated by LHX6 may
help inform molecular mechanisms of the alterations in PV and
SST neurons in schizophrenia.
KCNS3 mRNA, which is expressed selectively by the majority
of PV neurons in the PFC, encodes Kv9.3 voltage-gated K+
channel modulatory a-subunit. Modulatory a-subunits do not
assemble into homomeric channels, but selectively associate with
delayed rectifier Kv2 subunits to form functional heteromeric
channels [41]. In heterologous expression systems, Kv9.3 subunits
coassemble with Kv2.1 subunits, with a 1:3 subunit stoichiometry,
to form heteromeric Kv2.1/Kv9.3 channels [21]. Kv2.1 immu-
noreactivity has been detected in the soma and dendrites of most
cortical neurons, including PV neurons [42,43]. Therefore,
KCNS3 mRNA expression in PV neurons indicates the presence
of heteromeric Kv2.1/Kv9.3 channels in the soma and dendrites
of these neurons. Compared with homomeric Kv2.1 channels,
Kv2.1/Kv9.3 channels have modified characteristics, such as
larger single channel conductance, faster activation, slower
deactivation and inactivation, and shifted steady-state activation
and inactivation curves towards more negative values by <20 mV
[19,20]. Thus, Kv2.1/Kv9.3 channels are more effectively
activated by subthreshold membrane depolarizations such as
those generated by excitatory synaptic inputs. Interestingly, a
recent electrophysiological and modeling study demonstrated that
voltage-dependent K+ currents activated by excitatory post-
synaptic potentials (EPSPs) in PV neuron dendrites shorten both
the time course of EPSPs and the time window for the summation
of multiple EPSPs produced by excitatory synaptic inputs at
spatially separated dendritic sites [44]. Therefore, the presence of
Kv9.3 subunits might contribute to the fast excitatory synaptic
transmission and precise detection of coincident synaptic inputs in
PV neurons [45]. Kv3 channels, which are essential for the ability
of PV neurons to fire a train of short-duration action potentials at
high frequencies [46], were also implicated in fast EPSPs and
narrow time window of EPSP summation in PV neurons [44].
However, Kv3 channels are activated only by membrane
potentials more positive than approximately 210 mV that can
be attained during action potentials, but not synaptic EPSPs [46].
Therefore, Kv3 channels are unlikely to play a central role in
regulating time course and summation of EPSPs in PV neurons.
PV neurons play an essential role in the generation of cortical
gamma oscillations [47,48] that are important for cognitive
processes [49]. Because fast excitatory synaptic transmission and
precise coincident detection in PV neurons have been implicated
in the generation of gamma oscillations [50,51], our finding of
selective KCNS3 expression in PV neurons suggests that KCNS3-
encoded Kv9.3 subunits might contribute to the generation of
gamma oscillations by PV neurons. In subjects with schizophrenia,
alterations in GABA neurotransmission by PV neurons appear to
contribute to cognitive deficits by altering gamma oscillations
[3,52]. Currently, no Kv2.1-selective pharmacological modulators
are available [53] and, moreover, Kv2.1 subunits are ubiquitously
expressed by cortical neurons [42,43]. Therefore, the highly
selective expression of KCNS3 mRNA in PV neurons suggests
that Kv9.3 subunits might be a crucial target to modulate Kv2.1-
mediated delayed rectifier K+ currents and thus neuronal activity
in a PV neuron-selective manner. Pharmacological compounds
targeting Kv9.3 subunits might be useful to directly assess the
functional importance of Kv2.1/Kv9.3 currents in PV neurons
and for developing therapeutic strategies selectively targeting PV
neurons to modulate their role in the generation of gamma
oscillations.
Supporting Information
Figure S1 Identification of neurons specifically labeled
for KCNS3, LHX6, KCNAB1 and PPP1R2 mRNAs. (A, C,
E, G) High magnification view of Nissl-stained emulsion-coated
sections hybridized with 35S-labeled antisense riboprobes for each
of the four mRNAs (KCNS3, LHX6, KCNAB1 and PPP1R2).
Silver grain clusters were observed over large and faintly stained
neuronal nuclei, whereas small and more intensely stained glial
nuclei have few scattered grains. N+: neuron labeled with 35S-
labeled riboprobe, N-: neuron not labeled with 35S-labeled
riboprobe; G: glial cell not labeled with 35S-labeled riboprobe.
(B, D, F, H) Histograms showing the distribution of grain numbers
per cell for neurons and glial cells. Arrows indicate the average 56
background grain number per cell across all Nissl-stained sections
for each of the mRNAs.
(TIF)
Table S1 Primer sets used for cloning of DNA tem-
plates.
(DOC)
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